{"id":50174,"date":"2022-10-27T17:02:02","date_gmt":"2022-10-27T15:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-anti-counterfeit-pharmaceuticals-and-cosmetics-packaging-market-report-to-2030-featuring-zebra-technologies-u-nica-solutions-alien-technology-and-hague-among-others-researchandmarkets-com\/"},"modified":"2022-10-27T17:02:02","modified_gmt":"2022-10-27T15:02:02","slug":"global-anti-counterfeit-pharmaceuticals-and-cosmetics-packaging-market-report-to-2030-featuring-zebra-technologies-u-nica-solutions-alien-technology-and-hague-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-anti-counterfeit-pharmaceuticals-and-cosmetics-packaging-market-report-to-2030-featuring-zebra-technologies-u-nica-solutions-alien-technology-and-hague-among-others-researchandmarkets-com\/","title":{"rendered":"Global Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market Report to 2030 – Featuring Zebra Technologies, U-NICA Solutions, Alien Technology and Hague Among Others – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market By Technology, By Application: Global Opportunity Analysis and Industry Forecast, 2020-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global anti-counterfeit pharmaceuticals and cosmetics packaging market was valued at $81.1 billion in 2020, and is projected to reach $182.3 billion by 2030, growing at a CAGR of 8.4% from 2021 to 2030.\n<\/p>\n

\nAnti-counterfeit packaging is the process of securing and authenticating products in order to minimize counterfeiting or infringement malpractices across pharmaceuticals and cosmetics industries. Anti-counterfeiting packaging prevents imitation and confirms safety of goods.\n<\/p>\n

\nThe growth of the global anti-counterfeit pharmaceuticals and cosmetics packaging market is driven by advancement in track & trace technology and favorable government policies. Government authorities who are engaged in regulating and controlling counterfeit activities now provide legislative support to companies dealing with counterfeiting activities. Developed countries have established several regulatory policies for controlling counterfeit practices.\n<\/p>\n

\nFor example, in Germany, rules and regulations provide authority to manufacturers\/distributors\/affected parties, to take counter action against counterfeiters. Customs applications under the EU Customs Regulation (1383\/2003) and German IP laws, provide authority to find and seize counterfeited goods, which are being sold in the market or stored. These favorable government policies promote the commercial application of advance technology, ultimately driving the anti-counterfeit pharmaceuticals and cosmetics packaging market.\n<\/p>\n

\nHowever, high cost is required for implementing product identification setups (ground infrastructure). This high cost setup is not always feasible for low cost products. Such factors are not dominant in developed countries such as the U.S. and Europe due to favorable government support for ground infrastructure. However, in developing countries such as India, government finds it difficult to provide ground infrastructure, such as satellite for real time tracking to companies.\n<\/p>\n

\nOn the contrary, globalization gives rise to more trade across the borders, which creates a loophole for counterfeiters to foster and take advantage of such unmanaged businesses. The manufacturers in such cases are not in a position to track the actual location of their products while they are in transit.\n<\/p>\n

\nThis gives rise to a need of efficient supply chain management, which ends at one point i.e. adoption of anti-counterfeiting technology. For instance, counterfeited drugs of companies such as elokeen and Losec (Astra), Zantac (Glaxo) and Fansidar (Welcome) are being sold in EU States. The product chain of Zantac passes through four countries; the raw materials are collected from Turkey, manufactured in Greece, distributed through Swiss broker to Dutch Importer. Integrated security with multi-layered approach is the major focus of the high-end and luxury product manufacturers.\n<\/p>\n

\nThese industries are facing challenges at entry level of supply chain and finding difficult to maintain their brand integrity from the counterfeiting practices. Choosing a right type of multi-layered anti-counterfeit technology to authenticate the product is also a challenge for the manufacturers. This challenge in selecting the anti-counterfeit technologies is fueled by low volume high value manufacturers, in which the final products have been packed manually. This will increase the threat of counterfeiting at the point of packaging. All these factors are anticipated to offer new growth opportunities in the global anti-counterfeit pharmaceuticals and cosmetics packaging market.\n<\/p>\n

\nKey Benefits For Stakeholders<\/strong>\n<\/p>\n